349 results
8-K
EX-99.1
REGN
Regeneron Pharmaceuticals, Inc.
2 May 24
Regeneron Reports First Quarter 2024 Financial and Operating Results
7:06am
expenses that are recurring in nature. Furthermore, the Company's non-GAAP financial measures may not be comparable with non-GAAP information provided … contain these identifying words. These statements concern, and these risks and uncertainties include, among others, the nature, timing, and possible
8-K
EX-99.1
REGN
Regeneron Pharmaceuticals, Inc.
2 Feb 24
Regeneron Reports Fourth Quarter and Full Year 2023 Financial and Operating Results
7:16am
measures as they exclude certain expenses that are recurring in nature. Furthermore, the Company's non-GAAP financial measures may not be comparable … . These statements concern, and these risks and uncertainties include, among others, the nature, timing, and possible success and therapeutic applications
8-K
EX-99.1
hfeup3ffp5aj hcvjd
8 Jan 24
2 Strategy & Business Update J.P.Morgan Healthcare Conference 2024 Co - Founder, Board Co - Chair, President & Chief Executive Officer
6:30am
8-K
b2vfwe5qy0562 0ktnn
8 Jan 24
2 Strategy & Business Update J.P.Morgan Healthcare Conference 2024 Co - Founder, Board Co - Chair, President & Chief Executive Officer
6:30am
8-K
EX-99.1
40r xbn806
2 Nov 23
Regeneron Reports Third Quarter 2023 Financial and Operating Results
7:10am
8-K
nnt80q
5 Oct 23
Results of Operations and Financial Condition
4:04pm
SC TO-T/A
EX-99
hxy9pzc mubqz
25 Sep 23
Third party tender offer statement (amended)
8:48am
SC TO-T
EX-99
wmho77aopor1la3i5hc
25 Aug 23
Third party tender offer statement
7:46am
SC TO-T
EX-99
qeitr 4h7noe
25 Aug 23
Third party tender offer statement
7:46am
SC TO-C
rfuh6t0q16 ts6tjts
9 Aug 23
Information about tender offer
4:15pm
SC TO-C
EX-99.1
a5rtd
9 Aug 23
Information about tender offer
4:15pm
SC TO-C
EX-99.2
ql5glt6tnlsa5ja
9 Aug 23
Information about tender offer
4:15pm
8-K
EX-99.1
c70fxkvxy82 5c
3 Aug 23
Regeneron Reports Second Quarter 2023 Financial and Operating Results
6:48am
8-K
EX-99.1
mkb5vgpg3gumqk
4 May 23
Regeneron Reports First Quarter 2023 Financial and Operating Results
7:11am